Dr Divyya on Lancent retracting HCQ publication

Dr Shree Divyya, Manager in our healthcare advisory team comments on retracting of publication on hydroxychloroquine by very respected global journals, especially during a globally expanding pandemic.  Validated data to inform global response measures has been a scarce resource during COVID-19.  Further, such incidents have shaken confidence in the peer review process and global scientific community has raised questions about whether the journals can be held response.  We weigh in on implications and how such incidents can be overted in the future.


You might also like